Back to CAPTRUST Financial Advisors CAPTRUST Financial Advisors

VIVOVIVO

Showing 0 of 17 quarters

Position history for CAPTRUST Financial AdvisorsCAPTRUST Financial Advisors's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, CAPTRUST Financial Advisors held 7,397 shares of VIVO (Meridian Bioscience), worth $245,655. CAPTRUST Financial Advisors' 13F filings listed VIVO from Q2 2020 to Q4 2022, 11 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used